Prevalence and Incidence of Dry Eye Disease in Asia: A Systematic Review and Meta-Analysis
Abstract Background: Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence, and risk factors of DED in Asia would help in planning and implementing appropriate public health strategies. Objectives...
Saved in:
| Published in | Ophthalmic research Vol. 65; no. 6; pp. 647 - 658 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Basel, Switzerland
S. Karger AG
2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Abstract
Background: Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence, and risk factors of DED in Asia would help in planning and implementing appropriate public health strategies. Objectives: The present study aimed to study the epidemiology of DED in Asia. Methods: A comprehensive and systematic search was performed using several databases, including PubMed, Cochrane Library, and Web of Science, in January 2021. A random-effects meta-analysis was performed on logit-transformed prevalence and incidence rates to calculate pooled prevalence and incidence estimates. Meta-regression and subgroup analyses were performed to explain the heterogeneity. Results: Among the 6,742 articles identified, 23 were included in the analysis, with a total sample size of 1,488,935 subjects. Twenty studies reported the prevalence of DED in Asia, two studies reported the incidence, and one study reported both prevalence and incidence. The estimated pooled prevalence of DED in any population in Asia was 20.1% (95% confidence interval [Ozdemir et al., Acta Ophthalmol. 2019;97(1):e91–6]: 13.9–28.3%), and the incidence 16.7% (95% CI: 0–34.9%). The prevalence rate of DED in males and females was 16.4% (95% CI: 10.0–25.8%) and 21.7% (95% CI: 14.7–30.8%; p < 0.001), respectively. In general, the prevalence increased with age. The risk factors considered for specific populations were not significant, and the prevalence in the general population, excluding the populations considered at risk, was similar at 20.9% (95% CI: 12.8–32.1%). Conclusions: DED is common in Asian populations and causes a significant disease burden. Its prevalence is higher in females than that in males, and it tends to increase in severity with age. Further research on additional risk factors is needed to adequately explain the epidemiology of DED in Asia. |
|---|---|
| AbstractList | Abstract
Background: Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence, and risk factors of DED in Asia would help in planning and implementing appropriate public health strategies. Objectives: The present study aimed to study the epidemiology of DED in Asia. Methods: A comprehensive and systematic search was performed using several databases, including PubMed, Cochrane Library, and Web of Science, in January 2021. A random-effects meta-analysis was performed on logit-transformed prevalence and incidence rates to calculate pooled prevalence and incidence estimates. Meta-regression and subgroup analyses were performed to explain the heterogeneity. Results: Among the 6,742 articles identified, 23 were included in the analysis, with a total sample size of 1,488,935 subjects. Twenty studies reported the prevalence of DED in Asia, two studies reported the incidence, and one study reported both prevalence and incidence. The estimated pooled prevalence of DED in any population in Asia was 20.1% (95% confidence interval [Ozdemir et al., Acta Ophthalmol. 2019;97(1):e91–6]: 13.9–28.3%), and the incidence 16.7% (95% CI: 0–34.9%). The prevalence rate of DED in males and females was 16.4% (95% CI: 10.0–25.8%) and 21.7% (95% CI: 14.7–30.8%; p < 0.001), respectively. In general, the prevalence increased with age. The risk factors considered for specific populations were not significant, and the prevalence in the general population, excluding the populations considered at risk, was similar at 20.9% (95% CI: 12.8–32.1%). Conclusions: DED is common in Asian populations and causes a significant disease burden. Its prevalence is higher in females than that in males, and it tends to increase in severity with age. Further research on additional risk factors is needed to adequately explain the epidemiology of DED in Asia. Background: Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence, and risk factors of DED in Asia would help in planning and implementing appropriate public health strategies. Objectives: The present study aimed to study the epidemiology of DED in Asia. Methods: A comprehensive and systematic search was performed using several databases, including PubMed, Cochrane Library, and Web of Science, in January 2021. A random-effects meta-analysis was performed on logit-transformed prevalence and incidence rates to calculate pooled prevalence and incidence estimates. Meta-regression and subgroup analyses were performed to explain the heterogeneity. Results: Among the 6,742 articles identified, 23 were included in the analysis, with a total sample size of 1,488,935 subjects. Twenty studies reported the prevalence of DED in Asia, two studies reported the incidence, and one study reported both prevalence and incidence. The estimated pooled prevalence of DED in any population in Asia was 20.1% (95% confidence interval [Ozdemir et al., Acta Ophthalmol. 2019;97(1):e91-6]: 13.9-28.3%), and the incidence 16.7% (95% CI: 0-34.9%). The prevalence rate of DED in males and females was 16.4% (95% CI: 10.0-25.8%) and 21.7% (95% CI: 14.7-30.8%; p < 0.001), respectively. In general, the prevalence increased with age. The risk factors considered for specific populations were not significant, and the prevalence in the general population, excluding the populations considered at risk, was similar at 20.9% (95% CI: 12.8-32.1%). Conclusions: DED is common in Asian populations and causes a significant disease burden. Its prevalence is higher in females than that in males, and it tends to increase in severity with age. Further research on additional risk factors is needed to adequately explain the epidemiology of DED in Asia. Keywords: Dry eye disease, Prevalence, Incidence, Meta-analysis, Asia Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence, and risk factors of DED in Asia would help in planning and implementing appropriate public health strategies.BACKGROUNDDry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence, and risk factors of DED in Asia would help in planning and implementing appropriate public health strategies.The present study aimed to study the epidemiology of DED in Asia.OBJECTIVESThe present study aimed to study the epidemiology of DED in Asia.A comprehensive and systematic search was performed using several databases, including PubMed, Cochrane Library, and Web of Science, in January 2021. A random-effects meta-analysis was performed on logit-transformed prevalence and incidence rates to calculate pooled prevalence and incidence estimates. Meta-regression and subgroup analyses were performed to explain the heterogeneity.METHODSA comprehensive and systematic search was performed using several databases, including PubMed, Cochrane Library, and Web of Science, in January 2021. A random-effects meta-analysis was performed on logit-transformed prevalence and incidence rates to calculate pooled prevalence and incidence estimates. Meta-regression and subgroup analyses were performed to explain the heterogeneity.Among the 6,742 articles identified, 23 were included in the analysis, with a total sample size of 1,488,935 subjects. Twenty studies reported the prevalence of DED in Asia, two studies reported the incidence, and one study reported both prevalence and incidence. The estimated pooled prevalence of DED in any population in Asia was 20.1% (95% confidence interval [Ozdemir et al., Acta Ophthalmol. 2019;97(1):e91-6]: 13.9-28.3%), and the incidence 16.7% (95% CI: 0-34.9%). The prevalence rate of DED in males and females was 16.4% (95% CI: 10.0-25.8%) and 21.7% (95% CI: 14.7-30.8%; p < 0.001), respectively. In general, the prevalence increased with age. The risk factors considered for specific populations were not significant, and the prevalence in the general population, excluding the populations considered at risk, was similar at 20.9% (95% CI: 12.8-32.1%).RESULTSAmong the 6,742 articles identified, 23 were included in the analysis, with a total sample size of 1,488,935 subjects. Twenty studies reported the prevalence of DED in Asia, two studies reported the incidence, and one study reported both prevalence and incidence. The estimated pooled prevalence of DED in any population in Asia was 20.1% (95% confidence interval [Ozdemir et al., Acta Ophthalmol. 2019;97(1):e91-6]: 13.9-28.3%), and the incidence 16.7% (95% CI: 0-34.9%). The prevalence rate of DED in males and females was 16.4% (95% CI: 10.0-25.8%) and 21.7% (95% CI: 14.7-30.8%; p < 0.001), respectively. In general, the prevalence increased with age. The risk factors considered for specific populations were not significant, and the prevalence in the general population, excluding the populations considered at risk, was similar at 20.9% (95% CI: 12.8-32.1%).DED is common in Asian populations and causes a significant disease burden. Its prevalence is higher in females than that in males, and it tends to increase in severity with age. Further research on additional risk factors is needed to adequately explain the epidemiology of DED in Asia.CONCLUSIONSDED is common in Asian populations and causes a significant disease burden. Its prevalence is higher in females than that in males, and it tends to increase in severity with age. Further research on additional risk factors is needed to adequately explain the epidemiology of DED in Asia. Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence, and risk factors of DED in Asia would help in planning and implementing appropriate public health strategies. The present study aimed to study the epidemiology of DED in Asia. A comprehensive and systematic search was performed using several databases, including PubMed, Cochrane Library, and Web of Science, in January 2021. A random-effects meta-analysis was performed on logit-transformed prevalence and incidence rates to calculate pooled prevalence and incidence estimates. Meta-regression and subgroup analyses were performed to explain the heterogeneity. Among the 6,742 articles identified, 23 were included in the analysis, with a total sample size of 1,488,935 subjects. Twenty studies reported the prevalence of DED in Asia, two studies reported the incidence, and one study reported both prevalence and incidence. The estimated pooled prevalence of DED in any population in Asia was 20.1% (95% confidence interval [Ozdemir et al., Acta Ophthalmol. 2019;97(1):e91-6]: 13.9-28.3%), and the incidence 16.7% (95% CI: 0-34.9%). The prevalence rate of DED in males and females was 16.4% (95% CI: 10.0-25.8%) and 21.7% (95% CI: 14.7-30.8%; p < 0.001), respectively. In general, the prevalence increased with age. The risk factors considered for specific populations were not significant, and the prevalence in the general population, excluding the populations considered at risk, was similar at 20.9% (95% CI: 12.8-32.1%). DED is common in Asian populations and causes a significant disease burden. Its prevalence is higher in females than that in males, and it tends to increase in severity with age. Further research on additional risk factors is needed to adequately explain the epidemiology of DED in Asia. Background: Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence, and risk factors of DED in Asia would help in planning and implementing appropriate public health strategies. Objectives: The present study aimed to study the epidemiology of DED in Asia. Methods: A comprehensive and systematic search was performed using several databases, including PubMed, Cochrane Library, and Web of Science, in January 2021. A random-effects meta-analysis was performed on logit-transformed prevalence and incidence rates to calculate pooled prevalence and incidence estimates. Meta-regression and subgroup analyses were performed to explain the heterogeneity. Results: Among the 6,742 articles identified, 23 were included in the analysis, with a total sample size of 1,488,935 subjects. Twenty studies reported the prevalence of DED in Asia, two studies reported the incidence, and one study reported both prevalence and incidence. The estimated pooled prevalence of DED in any population in Asia was 20.1% (95% confidence interval [Ozdemir et al., Acta Ophthalmol. 2019;97(1):e91–6]: 13.9–28.3%), and the incidence 16.7% (95% CI: 0–34.9%). The prevalence rate of DED in males and females was 16.4% (95% CI: 10.0–25.8%) and 21.7% (95% CI: 14.7–30.8%; p < 0.001), respectively. In general, the prevalence increased with age. The risk factors considered for specific populations were not significant, and the prevalence in the general population, excluding the populations considered at risk, was similar at 20.9% (95% CI: 12.8–32.1%). Conclusions: DED is common in Asian populations and causes a significant disease burden. Its prevalence is higher in females than that in males, and it tends to increase in severity with age. Further research on additional risk factors is needed to adequately explain the epidemiology of DED in Asia. |
| Audience | Academic |
| Author | Zhou, Jiaxin Cai, Youran Zou, Wenjin Wei, Jintao |
| Author_xml | – sequence: 1 givenname: Youran surname: Cai fullname: Cai, Youran – sequence: 2 givenname: Jintao surname: Wei fullname: Wei, Jintao – sequence: 3 givenname: Jiaxin surname: Zhou fullname: Zhou, Jiaxin – sequence: 4 givenname: Wenjin surname: Zou fullname: Zou, Wenjin email: *Wenjin Zou, zouwj168@gmail.com |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35760054$$D View this record in MEDLINE/PubMed |
| BookMark | eNpt0c9PHCEUB3DSaHS1HnpvDEkv9TAKzABDbxNdfyQaG9teeiEs88ZQZ5gtzGrmv5d1VxPNhgOBfL4vvMce2vK9B4S-UHJMKVcnhBDOuFDiE5rQguUZYVxtoQkhOclyWchdtBfjP0ISVmQH7eZcipQpJujvzwCPpgVvARtf4ytvXf1y6ht8FkY8HQGfuQgmAnYeV9GZH7jCv8Y4QGcGZ_EdPDp4eknfwGCyypt2jC5-RtuNaSMcrPd99Od8-vv0Mru-vbg6ra4zywkbMq5Kxkxey4Ixy1khDbVSzYyYNTYn0uSFLQsOZUmFMkISNbNClo2Sgpe0rEW-j76v6s5D_38BcdCdixba1njoF1EzkRxlgspEv63ofWpZO9_0QzB2yXUlmWIlLcRSHW9QadXQOZtG37h0_y5wuH7BYtZBrefBdSaM-nXMCZysgA19jAEabd2Qhtf7VNm1mhK9_Ej99pEpcfQh8Vp0k1139WDCPYQ3eXs3XQk9r5ukvm5U6yLPJc2srQ |
| CitedBy_id | crossref_primary_10_1016_j_jtos_2025_01_006 crossref_primary_10_1016_j_clae_2022_101800 crossref_primary_10_1016_j_clae_2023_101845 crossref_primary_10_3390_ijms242216510 crossref_primary_10_1371_journal_pone_0288523 crossref_primary_10_1016_j_clae_2024_102353 crossref_primary_10_12968_opti_2024_270_6978_36 crossref_primary_10_1038_s41597_023_01931_8 crossref_primary_10_1080_02713683_2023_2262169 crossref_primary_10_3389_fpsyg_2024_1411661 crossref_primary_10_4103_IJO_IJO_2981_22 crossref_primary_10_1136_bmjophth_2024_002014 crossref_primary_10_1186_s12886_023_03250_3 crossref_primary_10_2147_OPTH_S427101 crossref_primary_10_1007_s10384_025_01175_6 crossref_primary_10_3389_fmed_2024_1359463 crossref_primary_10_1097_ICL_0000000000001101 crossref_primary_10_7759_cureus_40170 crossref_primary_10_1136_bmjopen_2024_090721 crossref_primary_10_3390_diagnostics14161796 crossref_primary_10_1016_j_clae_2024_102343 crossref_primary_10_1016_j_jtos_2025_01_010 crossref_primary_10_3390_life15030484 crossref_primary_10_1016_j_phymed_2024_155884 crossref_primary_10_18008_1816_5095_2024_2_264_269 crossref_primary_10_18231_j_ijooo_2023_035 crossref_primary_10_3390_life14070806 crossref_primary_10_1002_jgf2_576 crossref_primary_10_3390_medicina61030460 crossref_primary_10_4103_joco_joco_46_24 crossref_primary_10_1016_j_exer_2023_109676 crossref_primary_10_5114_reum_197334 crossref_primary_10_1002_prp2_70077 crossref_primary_10_1080_09273948_2023_2285449 crossref_primary_10_1186_s12886_024_03565_9 crossref_primary_10_3390_ph17020175 crossref_primary_10_7759_cureus_70522 crossref_primary_10_1038_s41598_024_68070_x crossref_primary_10_1097_OPX_0000000000002102 crossref_primary_10_1097_MD_0000000000041019 crossref_primary_10_1177_25158163241287456 crossref_primary_10_17337_JMBI_2023_25_4_465 crossref_primary_10_3390_medicina60060985 crossref_primary_10_4103_IJO_IJO_2663_22 |
| Cites_doi | https://doi.org/10.1186/s12886-018-0825-z https://doi.org/10.1111/ceo.12183 https://doi.org/10.1016/j.jtos.2020.07.016 https://doi.org/10.1097/icl.0000000000000626 https://doi.org/10.1001/archophthalmol.2009.103 https://doi.org/10.1016/j.ajo.2013.05.040 https://doi.org/10.1155/2019/8509089 https://doi.org/10.1111/opo.12888 https://doi.org/10.1016/j.jtos.2019.04.004 https://doi.org/10.1159/000509060 https://doi.org/10.1016/j.ajo.2019.02.024 https://doi.org/10.1080/09286586.2016.1263996 https://doi.org/10.1016/j.clae.2020.12.067 https://doi.org/10.1371/journal.pmed.1000097 https://doi.org/10.1111/cxo.12210 https://doi.org/10.1016/j.pcd.2020.01.011 https://doi.org/10.1097/ico.0b013e3182261590 https://doi.org/10.1186/s12886-016-0364-4 https://doi.org/10.1371/journal.pone.0039313 https://doi.org/10.1016/j.jtos.2019.02.007 https://doi.org/10.1080/02713683.2019.1641827 https://doi.org/10.1016/j.ajo.2017.06.033 https://doi.org/10.7189/jogh.08.020503 https://doi.org/10.2147/opth.s240057 https://doi.org/10.1038/srep35276 https://doi.org/10.1016/j.jtos.2017.05.001 https://doi.org/10.4103/ijo.ijo_698_17 https://doi.org/10.1016/j.jtos.2019.02.011 https://doi.org/10.1007/s00266-020-01874-0 https://doi.org/10.1001/jamaophthalmol.2019.4815 https://doi.org/10.1136/bmj.327.7414.557 https://doi.org/10.1111/aos.12012 https://doi.org/10.1007/s10792-017-0590-7 https://doi.org/10.1016/j.jtos.2017.05.003 https://doi.org/10.1111/ceo.13146 https://doi.org/10.1097/icl.0000000000000064 https://doi.org/10.1097/opx.0000000000001610 https://doi.org/10.1136/bmjopen-2014-005296 https://doi.org/10.1016/j.jtos.2016.09.003 https://doi.org/10.1056/nejmra1407936 https://doi.org/10.1007/s10654-010-9491-z https://doi.org/10.1080/09286586.2019.1607882 https://doi.org/10.1539/joh.14-0243-oa https://doi.org/10.1186/s12886-018-0781-7 https://doi.org/10.1111/aos.13829 https://doi.org/10.1186/s12886-019-1290-z https://doi.org/10.1007/s12325-019-01143-w |
| ContentType | Journal Article |
| Copyright | 2022 The Author(s). Published by S. Karger AG, Basel 2022 The Author(s). Published by S. Karger AG, Basel. COPYRIGHT 2022 S. Karger AG |
| Copyright_xml | – notice: 2022 The Author(s). Published by S. Karger AG, Basel – notice: 2022 The Author(s). Published by S. Karger AG, Basel. – notice: COPYRIGHT 2022 S. Karger AG |
| DBID | M-- AAYXX CITATION NPM 7X8 |
| DOI | 10.1159/000525696 |
| DatabaseName | Karger Open Access Journals CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: M-- name: Karger Open Access Journals url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1423-0259 |
| EndPage | 658 |
| ExternalDocumentID | A729281467 35760054 10_1159_000525696 525696 |
| Genre | Meta-Analysis |
| GeographicLocations | East Asia Japan China India |
| GeographicLocations_xml | – name: East Asia – name: China – name: India – name: Japan |
| GroupedDBID | --- 0~B 123 29N 3O. 4.4 5RE 8UI AAYIC ABPAZ ACGFS ACNCT ACPRK ACPSR ADBBV AENEX AEYAO AFRAH AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC CS3 CYUIP DU5 E0A EBS EMOBN F5P FB. GROUPED_DOAJ HZ~ IAO IHR INH IY7 KUZGX M-- N9A O1H O9- OK1 RKO UJ6 WH7 .GJ 0~5 30W 329 34G 39C 3O- 53G 7X7 88E 8AO 8FI 8FJ 8FW AALGM AAYXX ABBTS ABJNI ABUWG ABWCG ACQXL ADAGL AFJJK AFKRA AFSIO AHFRZ BENPR BPHCQ BVXVI CAG CCPQU CITATION COF EJD FYUFA HMCUK ITC M1P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO RIG RXVBD UKHRP ZGI ZXP 3V. NPM 7X8 |
| ID | FETCH-LOGICAL-c502t-59822a3d7422c5247a1c79ba6bfc307a34c845e88169a6709bc678f9765818d63 |
| IEDL.DBID | M-- |
| ISSN | 0030-3747 1423-0259 |
| IngestDate | Fri Jul 11 08:20:24 EDT 2025 Wed Mar 19 02:15:09 EDT 2025 Sat Mar 08 18:57:29 EST 2025 Wed Feb 19 02:26:27 EST 2025 Tue Aug 05 11:57:53 EDT 2025 Thu Apr 24 23:06:00 EDT 2025 Sat Aug 31 21:00:33 EDT 2024 Thu Aug 29 12:04:26 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Prevalence Asia Dry eye disease Incidence Meta-analysis |
| Language | English |
| License | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. https://creativecommons.org/licenses/by-nc/4.0 2022 The Author(s). Published by S. Karger AG, Basel. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c502t-59822a3d7422c5247a1c79ba6bfc307a34c845e88169a6709bc678f9765818d63 |
| Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Undefined-1 content type line 23 ObjectType-Article-3 |
| OpenAccessLink | https://karger.com/doi/10.1159/000525696 |
| PMID | 35760054 |
| PQID | 2681812617 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | gale_infotracacademiconefile_A729281467 proquest_miscellaneous_2681812617 karger_primary_525696 gale_infotracmisc_A729281467 crossref_citationtrail_10_1159_000525696 crossref_primary_10_1159_000525696 pubmed_primary_35760054 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-00-00 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – year: 2022 text: 2022-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Basel, Switzerland |
| PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland |
| PublicationTitle | Ophthalmic research |
| PublicationTitleAlternate | Ophthalmic Res |
| PublicationYear | 2022 |
| Publisher | S. Karger AG |
| Publisher_xml | – name: S. Karger AG |
| References | Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, . Celiac disease. Evid Rep Technol Assess. 2004(104):1–6. Uchino M, Yokoi N, Uchino Y, Dogru M, Kawashima M, Komuro A, . Prevalence of dry eye disease and its risk factors in visual display terminal users: the osaka study. Am J Ophthalmol. 2013;156(4):759–66.e1. Kobia-Acquah E, Ankamah-Lomotey S, Owusu E, Forfoe S, Bannor J, Koomson JA, . Prevalence and associated risk factors of symptomatic dry eye in Ghana: a cross-sectional population-based study. Cont Lens Anterior Eye. 2021;44(6):101404. Tan LL, Morgan P, Cai ZQ, Straughan RA. Prevalence of and risk factors for symptomatic dry eye disease in Singapore. Clin Exp Optom. 2015;98(1):45–53. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003;327(7414):557–60. Li S, He J, Chen Q, Zhu J, Zou H, Xu X. Ocular surface health in Shanghai University students: a cross-sectional study. BMC Ophthalmol. 2018;18(1):245. Ward MF2nd, LeP, Donaldson JC, Van Buren E, Lin FC, Lefebvre C, . Racial and ethnic differences in the association between diabetes mellitus and dry eye disease. Ophthalmic Epidemiol. 2019;26(5):295–300. Caffery B, Srinivasan S, Reaume CJ, Fischer A, Cappadocia D, Siffel C. Prevalence of dry eye disease in Ontario, Canada: a population-based survey. Ocul Surf. 2019;17(3):526–31. Ozdemir HB, Kalkanci A, Bilgihan K, Gocun PU, Ogut B, Karakurt F, . Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis. Acta Ophthalmol. 2019;97(1):e91–6. Wen W, Wu Y, Chen Y, Gong L, Li M, Chen X, . Dry eye disease in patients with depressive and anxiety disorders in Shanghai. Cornea. 2012;31(6):686–92. Ayaki M, Kawashima M, Negishi K, Kishimoto T, Mimura M, Tsubota K. Sleep and mood disorders in women with dry eye disease. Scientific Rep. 2016;6(1):35276. Arita R, Mizoguchi T, Kawashima M, Fukuoka S, Koh S, Shirakawa R, . Meibomian gland dysfunction and dry eye are similar but different based on a population-based study: the hirado-takushima study in Japan. Am J Ophthalmol. 2019;207:410–8. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med. 2009;6(7):e1000097. Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, . Characteristics and risk factors associated with diagnosed and undiagnosed symptomatic dry eye using a smartphone application. JAMA Ophthalmol. 2020;138(1):58. Yan Y, Zhou Y, Zhang S, Cui C, Song X, Zhu X, . Impact of full-incision double-eyelid blepharoplasty on tear film dynamics and dry eye symptoms in young asian females. Aesthetic Plast Surg. 2020;44(6):2109–16. Ma A, Mak MSY, Shih KC, Tsui CKY, Cheung RKY, Lee SH, . Association of long-term glycaemic control on tear break-up times and dry eye symptoms in Chinese patients with type 2 diabetes. Clin Exp Ophthalmol. 2018;46(6):608–15. Titiyal JS, Falera RC, Kaur M, Sharma V, Sharma N. Prevalence and risk factors of dry eye disease in North India: ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol. 2018;66(2):207–11. Keratology Group of Ophthalmology Branch of Chinese Medical Association. Consensus of experts on diagnosis and treatment of neurotrophic keratitis in China (2021). Zhonghua Yan Ke Za Zhi. 2021;57(2):90–4. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. Yusufu M, Liu X, Zheng T, Fan F, Xu J, Luo Y. Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients. Int Ophthalmol. 2018;38(3):1261–73. Bazeer S, Jansonius N, Snieder H, Hammond C, Vehof J. The relationship between occupation and dry eye. Ocul Surf. 2019;17(3):484–90. Zou X, Lu L, Xu Y, Zhu J, He J, Zhang B, . Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study. BMC Ophthalmol. 2018;18(1):117. Farrand KF, Fridman M, Stillman IÖ, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 Years and older. Am J Ophthalmol. 2017;182:90–8. Gong YY, Zhang F, Zhou J, Li J, Zhang GH, Wang JL, . Prevalence of dry eye in Uyghur and han ethnic groups in western China. Ophthalmic Epidemiol. 2017;24(3):181–7. Clayton JA. Dry Eye. N Engl J Med. 2018;378(23):2212–23. Shanti Y, Shehada R, Bakkar MM, Qaddumi J. Prevalence and associated risk factors of dry eye disease in 16 northern West bank towns in Palestine: a cross-sectional study. BMC Ophthalmol. 2020;20(1):26. Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, . TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–74. Li M, Zeng L, Mi S, Li Y, Liu Z, Yu K, . A multicenter study of the prevalence of dry eye disease in Chinese refractive surgery candidates. Ophthalmic Res. 2021;64(2):224–9. Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 Years and older. Am J Ophthalmol. 2017;182:90–8. Donthineni PR, Kammari P, Shanbhag SS, Singh V, Das AV, Basu S. Incidence, demographics, types and risk factors of dry eye disease in India: electronic medical records driven big data analytics report I. Ocul Surf. 2019;17(2):250–6. Hashemi H, Khabazkhoob M, Kheirkhah A, Emamian MH, Mehravaran S, Shariati M, . Prevalence of dry eye syndrome in an adult population. Clin Exp Ophthalmol. 2014;42(3):242–8. Xu L, Wang YX, Guo Y, You QS, Jonas JB. Prevalence and associations of steep cornea/keratoconus in greater beijing. The beijing eye study. PLoS One. 2012;7(7):e39313. Akowuah PK, Kobia-Acquah E. Prevalence of dry eye disease in Africa: a systematic review and meta-analysis. Optom Vis Sci. 2020;97(12):1089–98. Papas EB. The global prevalence of dry eye disease: a Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254–66. Tandon R, Vashist P, Gupta N, Gupta V, Sahay P, Deka D, . Association of dry eye disease and sun exposure in geographically diverse adult (≥40 years) populations of India: the SEED (sun exposure, environment and dry eye disease) study: second report of the ICMR-EYE SEE study group. Ocul Surf. 2020;18(4):718–30. De Freitas GR, Ferraz GAM, Gehlen M, Skare TL. Dry eyes in patients with diabetes mellitus. Prim Care Diabetes. 2021;15(1):184–6. Kawashima M, Yamatsuji M, Yokoi N, Fukui M, Ichihashi Y, Kato H, . Screening of dry eye disease in visual display terminal workers during occupational health examinations: the Moriguchi study. J Occup Health. 2015;57(3):253–8. Song P, Xia W, Wang M, Chang X, Wang J, Jin S, . Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis. J Glob Health. 2018;8(2):020503. Huang X, Zhang P, Zou X, Xu Y, Zhu J, He J, . Two-year incidence and associated factors of dry eye among residents in shanghai communities with type 2 diabetes mellitus. Eye Contact Lens. 2020;46(1):S42–49. Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, . Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92(2):161–6. Wang A, Gu Z, Liao R, Shuai Z. Dry eye indexes estimated by keratograph 5M of systemic lupus erythematosus patients without secondary sjogren’s syndrome correlate with lupus activity. J Ophthalmol. 2019;2019:1–8. Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, . New perspectives on dry eye definition and diagnosis: a consensus report by the Asia dry eye society. Ocul Surf. 2017;15(1):65–76. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, . TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–65. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127(6):763. Shimazaki J, Nomura Y, Numa S, Murase Y, Kakinoki K, Abe F, . Prospective, multicenter, cross-sectional survey on dry eye disease in Japan. Adv Ther. 2020;37(1):316–28. Wang S, Jia Y, Li T, Wang A, Gao L, Yang C, . Dry eye disease is more prevalent in children with diabetes than in those without diabetes. Curr Eye Res. 2019;44(12):1299–305. Li J, Zheng K, Deng Z, Zheng J, Ma H, Sun L, . Prevalence and risk factors of dry eye disease among a hospital-based population in southeast China. Eye Contact Lens. 2015;41(1):44–50. Noor NA, Rahayu T, Gondhowiardjo TD. Prevalence of dry eye and its subtypes in an elderly population with cataracts in Indonesia. Clin Ophthalmol. 2020;14:2143–150. Moon JH, Kim KW, Moon NJ. Smartphone use is a risk factor for pediatric dry eye disease according to region and age: a case control study. BMC Ophthalmol. 2016;16(1):188. Hua R, Yao K, Hu Y, Chen L. Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population based analysis. BMJ Open. 2014;4(8):e005296. ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref46 ref23 ref45 ref26 ref48 ref25 ref47 ref20 ref42 ref41 ref22 ref44 ref21 ref43 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
| References_xml | – reference: Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, . Celiac disease. Evid Rep Technol Assess. 2004(104):1–6. – reference: Kawashima M, Yamatsuji M, Yokoi N, Fukui M, Ichihashi Y, Kato H, . Screening of dry eye disease in visual display terminal workers during occupational health examinations: the Moriguchi study. J Occup Health. 2015;57(3):253–8. – reference: Uchino M, Yokoi N, Uchino Y, Dogru M, Kawashima M, Komuro A, . Prevalence of dry eye disease and its risk factors in visual display terminal users: the osaka study. Am J Ophthalmol. 2013;156(4):759–66.e1. – reference: Kobia-Acquah E, Ankamah-Lomotey S, Owusu E, Forfoe S, Bannor J, Koomson JA, . Prevalence and associated risk factors of symptomatic dry eye in Ghana: a cross-sectional population-based study. Cont Lens Anterior Eye. 2021;44(6):101404. – reference: Wang A, Gu Z, Liao R, Shuai Z. Dry eye indexes estimated by keratograph 5M of systemic lupus erythematosus patients without secondary sjogren’s syndrome correlate with lupus activity. J Ophthalmol. 2019;2019:1–8. – reference: Titiyal JS, Falera RC, Kaur M, Sharma V, Sharma N. Prevalence and risk factors of dry eye disease in North India: ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol. 2018;66(2):207–11. – reference: Hashemi H, Khabazkhoob M, Kheirkhah A, Emamian MH, Mehravaran S, Shariati M, . Prevalence of dry eye syndrome in an adult population. Clin Exp Ophthalmol. 2014;42(3):242–8. – reference: Zou X, Lu L, Xu Y, Zhu J, He J, Zhang B, . Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study. BMC Ophthalmol. 2018;18(1):117. – reference: Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, . Characteristics and risk factors associated with diagnosed and undiagnosed symptomatic dry eye using a smartphone application. JAMA Ophthalmol. 2020;138(1):58. – reference: De Freitas GR, Ferraz GAM, Gehlen M, Skare TL. Dry eyes in patients with diabetes mellitus. Prim Care Diabetes. 2021;15(1):184–6. – reference: Xu L, Wang YX, Guo Y, You QS, Jonas JB. Prevalence and associations of steep cornea/keratoconus in greater beijing. The beijing eye study. PLoS One. 2012;7(7):e39313. – reference: Li M, Zeng L, Mi S, Li Y, Liu Z, Yu K, . A multicenter study of the prevalence of dry eye disease in Chinese refractive surgery candidates. Ophthalmic Res. 2021;64(2):224–9. – reference: Caffery B, Srinivasan S, Reaume CJ, Fischer A, Cappadocia D, Siffel C. Prevalence of dry eye disease in Ontario, Canada: a population-based survey. Ocul Surf. 2019;17(3):526–31. – reference: Huang X, Zhang P, Zou X, Xu Y, Zhu J, He J, . Two-year incidence and associated factors of dry eye among residents in shanghai communities with type 2 diabetes mellitus. Eye Contact Lens. 2020;46(1):S42–49. – reference: Yan Y, Zhou Y, Zhang S, Cui C, Song X, Zhu X, . Impact of full-incision double-eyelid blepharoplasty on tear film dynamics and dry eye symptoms in young asian females. Aesthetic Plast Surg. 2020;44(6):2109–16. – reference: Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003;327(7414):557–60. – reference: Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med. 2009;6(7):e1000097. – reference: Papas EB. The global prevalence of dry eye disease: a Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254–66. – reference: Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, . New perspectives on dry eye definition and diagnosis: a consensus report by the Asia dry eye society. Ocul Surf. 2017;15(1):65–76. – reference: Wen W, Wu Y, Chen Y, Gong L, Li M, Chen X, . Dry eye disease in patients with depressive and anxiety disorders in Shanghai. Cornea. 2012;31(6):686–92. – reference: Ward MF2nd, LeP, Donaldson JC, Van Buren E, Lin FC, Lefebvre C, . Racial and ethnic differences in the association between diabetes mellitus and dry eye disease. Ophthalmic Epidemiol. 2019;26(5):295–300. – reference: Moon JH, Kim KW, Moon NJ. Smartphone use is a risk factor for pediatric dry eye disease according to region and age: a case control study. BMC Ophthalmol. 2016;16(1):188. – reference: Bazeer S, Jansonius N, Snieder H, Hammond C, Vehof J. The relationship between occupation and dry eye. Ocul Surf. 2019;17(3):484–90. – reference: Keratology Group of Ophthalmology Branch of Chinese Medical Association. Consensus of experts on diagnosis and treatment of neurotrophic keratitis in China (2021). Zhonghua Yan Ke Za Zhi. 2021;57(2):90–4. – reference: Shanti Y, Shehada R, Bakkar MM, Qaddumi J. Prevalence and associated risk factors of dry eye disease in 16 northern West bank towns in Palestine: a cross-sectional study. BMC Ophthalmol. 2020;20(1):26. – reference: Shimazaki J, Nomura Y, Numa S, Murase Y, Kakinoki K, Abe F, . Prospective, multicenter, cross-sectional survey on dry eye disease in Japan. Adv Ther. 2020;37(1):316–28. – reference: Ozdemir HB, Kalkanci A, Bilgihan K, Gocun PU, Ogut B, Karakurt F, . Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis. Acta Ophthalmol. 2019;97(1):e91–6. – reference: Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. – reference: Clayton JA. Dry Eye. N Engl J Med. 2018;378(23):2212–23. – reference: Song P, Xia W, Wang M, Chang X, Wang J, Jin S, . Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis. J Glob Health. 2018;8(2):020503. – reference: Arita R, Mizoguchi T, Kawashima M, Fukuoka S, Koh S, Shirakawa R, . Meibomian gland dysfunction and dry eye are similar but different based on a population-based study: the hirado-takushima study in Japan. Am J Ophthalmol. 2019;207:410–8. – reference: Gong YY, Zhang F, Zhou J, Li J, Zhang GH, Wang JL, . Prevalence of dry eye in Uyghur and han ethnic groups in western China. Ophthalmic Epidemiol. 2017;24(3):181–7. – reference: Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 Years and older. Am J Ophthalmol. 2017;182:90–8. – reference: Wang S, Jia Y, Li T, Wang A, Gao L, Yang C, . Dry eye disease is more prevalent in children with diabetes than in those without diabetes. Curr Eye Res. 2019;44(12):1299–305. – reference: Tan LL, Morgan P, Cai ZQ, Straughan RA. Prevalence of and risk factors for symptomatic dry eye disease in Singapore. Clin Exp Optom. 2015;98(1):45–53. – reference: Ayaki M, Kawashima M, Negishi K, Kishimoto T, Mimura M, Tsubota K. Sleep and mood disorders in women with dry eye disease. Scientific Rep. 2016;6(1):35276. – reference: Li J, Zheng K, Deng Z, Zheng J, Ma H, Sun L, . Prevalence and risk factors of dry eye disease among a hospital-based population in southeast China. Eye Contact Lens. 2015;41(1):44–50. – reference: Yusufu M, Liu X, Zheng T, Fan F, Xu J, Luo Y. Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients. Int Ophthalmol. 2018;38(3):1261–73. – reference: Hua R, Yao K, Hu Y, Chen L. Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population based analysis. BMJ Open. 2014;4(8):e005296. – reference: Li S, He J, Chen Q, Zhu J, Zou H, Xu X. Ocular surface health in Shanghai University students: a cross-sectional study. BMC Ophthalmol. 2018;18(1):245. – reference: Donthineni PR, Kammari P, Shanbhag SS, Singh V, Das AV, Basu S. Incidence, demographics, types and risk factors of dry eye disease in India: electronic medical records driven big data analytics report I. Ocul Surf. 2019;17(2):250–6. – reference: Noor NA, Rahayu T, Gondhowiardjo TD. Prevalence of dry eye and its subtypes in an elderly population with cataracts in Indonesia. Clin Ophthalmol. 2020;14:2143–150. – reference: Farrand KF, Fridman M, Stillman IÖ, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 Years and older. Am J Ophthalmol. 2017;182:90–8. – reference: Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, . TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–65. – reference: Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127(6):763. – reference: Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, . TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–74. – reference: Ma A, Mak MSY, Shih KC, Tsui CKY, Cheung RKY, Lee SH, . Association of long-term glycaemic control on tear break-up times and dry eye symptoms in Chinese patients with type 2 diabetes. Clin Exp Ophthalmol. 2018;46(6):608–15. – reference: Akowuah PK, Kobia-Acquah E. Prevalence of dry eye disease in Africa: a systematic review and meta-analysis. Optom Vis Sci. 2020;97(12):1089–98. – reference: Tandon R, Vashist P, Gupta N, Gupta V, Sahay P, Deka D, . Association of dry eye disease and sun exposure in geographically diverse adult (≥40 years) populations of India: the SEED (sun exposure, environment and dry eye disease) study: second report of the ICMR-EYE SEE study group. Ocul Surf. 2020;18(4):718–30. – reference: Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, . Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92(2):161–6. – ident: ref26 doi: https://doi.org/10.1186/s12886-018-0825-z – ident: ref32 doi: https://doi.org/10.1111/ceo.12183 – ident: ref20 doi: https://doi.org/10.1016/j.jtos.2020.07.016 – ident: ref18 doi: https://doi.org/10.1097/icl.0000000000000626 – ident: ref6 doi: https://doi.org/10.1001/archophthalmol.2009.103 – ident: ref35 doi: https://doi.org/10.1016/j.ajo.2013.05.040 – ident: ref38 doi: https://doi.org/10.1155/2019/8509089 – ident: ref39 doi: https://doi.org/10.1111/opo.12888 – ident: ref44 doi: https://doi.org/10.1016/j.jtos.2019.04.004 – ident: ref19 doi: https://doi.org/10.1159/000509060 – ident: ref25 doi: https://doi.org/10.1016/j.ajo.2019.02.024 – ident: ref31 doi: https://doi.org/10.1080/09286586.2016.1263996 – ident: ref45 doi: https://doi.org/10.1016/j.clae.2020.12.067 – ident: ref10 doi: https://doi.org/10.1371/journal.pmed.1000097 – ident: ref9 doi: https://doi.org/10.1111/cxo.12210 – ident: ref47 doi: https://doi.org/10.1016/j.pcd.2020.01.011 – ident: ref23 doi: https://doi.org/10.1097/ico.0b013e3182261590 – ident: ref34 doi: https://doi.org/10.1186/s12886-016-0364-4 – ident: ref8 doi: https://doi.org/10.1371/journal.pone.0039313 – ident: ref17 doi: https://doi.org/10.1016/j.jtos.2019.02.007 – ident: ref24 doi: https://doi.org/10.1080/02713683.2019.1641827 – ident: ref7 doi: https://doi.org/10.1016/j.ajo.2017.06.033 – ident: ref41 doi: https://doi.org/10.7189/jogh.08.020503 – ident: ref30 doi: https://doi.org/10.2147/opth.s240057 – ident: ref12 doi: https://doi.org/10.1038/srep35276 – ident: ref13 doi: https://doi.org/10.1016/j.jtos.2017.05.001 – ident: ref48 doi: https://doi.org/10.4103/ijo.ijo_698_17 – ident: ref43 doi: https://doi.org/10.1016/j.jtos.2019.02.011 – ident: ref37 doi: https://doi.org/10.1007/s00266-020-01874-0 – ident: ref4 doi: https://doi.org/10.1001/jamaophthalmol.2019.4815 – ident: ref15 doi: https://doi.org/10.1136/bmj.327.7414.557 – ident: ref40 doi: https://doi.org/10.1111/aos.12012 – ident: ref36 doi: https://doi.org/10.1007/s10792-017-0590-7 – ident: ref3 doi: https://doi.org/10.1016/j.jtos.2017.05.003 – ident: ref21 doi: https://doi.org/10.1111/ceo.13146 – ident: ref29 doi: https://doi.org/10.1097/icl.0000000000000064 – ident: ref46 doi: https://doi.org/10.1097/opx.0000000000001610 – ident: ref22 doi: https://doi.org/10.1136/bmjopen-2014-005296 – ident: ref42 doi: https://doi.org/10.1016/j.ajo.2017.06.033 – ident: ref11 doi: https://doi.org/10.1016/j.jtos.2016.09.003 – ident: ref2 doi: https://doi.org/10.1056/nejmra1407936 – ident: ref14 doi: https://doi.org/10.1007/s10654-010-9491-z – ident: ref5 doi: https://doi.org/10.1080/09286586.2019.1607882 – ident: ref33 doi: https://doi.org/10.1539/joh.14-0243-oa – ident: ref28 doi: https://doi.org/10.1186/s12886-018-0781-7 – ident: ref1 doi: https://doi.org/10.1111/aos.13829 – ident: ref27 doi: https://doi.org/10.1186/s12886-019-1290-z – ident: ref16 doi: https://doi.org/10.1007/s12325-019-01143-w |
| SSID | ssj0015990 |
| Score | 2.485017 |
| SecondaryResourceType | review_article |
| Snippet | Abstract
Background: Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the... Background: Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence,... Dry eye disease (DED) is the most common ocular surface disease, which severely affects the quality of life. An overall estimate of the prevalence, incidence,... |
| SourceID | proquest gale pubmed crossref karger |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 647 |
| SubjectTerms | Analysis Epidemiology Eye diseases Medical research Medicine, Experimental Meta-Analysis |
| Title | Prevalence and Incidence of Dry Eye Disease in Asia: A Systematic Review and Meta-Analysis |
| URI | https://karger.com/doi/10.1159/000525696 https://www.ncbi.nlm.nih.gov/pubmed/35760054 https://www.proquest.com/docview/2681812617 |
| Volume | 65 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1ZS8QwEB68EF_E2-oqUQR9Cdgm6ba-Lboiwip4gPhSchVE6YquD_57J0cLK_raXCWTyXyTyXwBOEIQUvDU1NSitUcHRTEqOTM0lRnjuZKCKZecPLrJrx759ZN4iucdLhfm1d1_9tSoHbcAGlz_9Bwa5zKfhXn0o5i7vDeitIsXiLKMBIy4qyBCjhxCU02XYJEJF4cSfMoIxa14IQz9P9L0FudyBZYjVCSDINtVmLHNGiyOYjB8HZ4d_ZL0SUNENoagqocXQsm4Jhcf32T4bclFCMCQl4YMPl_kGRmQ-468mYTIgG89shNJW4qSDXi8HD6cX9H4VALV4jSbUE_DJ5lBRzfTIuN9mep-qWSuao1aLBnXBRe2KNK8lI6yTWm0UjViEYEW2-RsE-aacWO3gaBGp30slalUvDayzERRW85UbRBqCZPASTt3lY484u45i7fK-xOirLoZT-Cwq_oeyDP-qnTsBFA5hcJ-tIx5Afg3jpqqGiD8z9xBZT-B3lRNVAQ9VbwRRNiN1Q7Q-_X99m4Yiqp3Uydw0Aq8cj26S2eNHX99VlleOPyDGC-BrbASui7albTzz6C7sJS5RAl_WNODucnHl91D-DJR-97t3_fr9wfIYuMA |
| linkProvider | Karger AG |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VgtpeEI8CgQUMAsHFEnHsJEbisGK32tKmSNBKFZdgx45UFWWr7lZo_wk_l_EjkRbRY6-xYyee8Tw8nm8A3qARUvLUtNSitkcHRWdU8czQVLGM51qJTLvk5Ooon53wL6fidAP-9Lkw5-7-s4dGHbAFUOH60nOonGUer08e2NVvdM4Wn_YnSMm3jO1Njz_PaKwfQBvxgS2px6ZTmUHvjzWC8UKlTSG1ynXbIGurjDclF7Ys01wqh2OmGxTdLSpogWrM5BmOewtuFzKXDpW_onSITwgpI-AjSjG0yCNm0dqn7sBWJlzcS_A1pRdF_53wq9dbtl7D7d2Du9E0JePAS_dhw3YPYKuKwfeH8MPBPSmfpERUZwiKllCRlMxbMrlckenKkkkI-JCzjowXZ-ojGZPvA1g0CZEI_3Zll4r2kCi7cHIjS_sINrt5Z58AQQmSFtiqUqV5a5Rkomwtz3Rr0LQTJoH3_drVTcQtd-UzftXefxGyHlY8gddD14sA1vG_Tu8cAWq3gXGcRsU8BPwaB4VVj9HdYO5gtEhgtNYTN16z1rwbSDjM1U8w-uf512_T0FRfmDaBVz3Bazeiu-TW2fnVomZ56ewttCkTeBw4YRii56Sn10z6ErZnx9Vhfbh_dPAMdphL0vAHRSPYXF5e2edoOi31C8_FBH7e9Lb5C3heHOQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+Incidence+of+Dry+Eye+Disease+in+Asia%3A+A+Systematic+Review+and+Meta-Analysis&rft.jtitle=Ophthalmic+research&rft.au=Cai%2C+Youran&rft.au=Wei%2C+Jintao&rft.au=Zhou%2C+Jiaxin&rft.au=Zou%2C+Wenjin&rft.date=2022&rft.issn=0030-3747&rft.eissn=1423-0259&rft.volume=65&rft.issue=6&rft.spage=647&rft.epage=658&rft_id=info:doi/10.1159%2F000525696&rft_id=info%3Apmid%2F35760054&rft.externalDocID=525696 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0030-3747&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0030-3747&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0030-3747&client=summon |